Molecular background of progressive myoclonus epilepsy

EMBO Journal

Volumn 22, Issue 14, 2003, Pages 3473-3478

  Lehesjoki, Anna Elina ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Apoptosis; Cystatin B; EPM1; Neurodegeneration; Progressive myoclonus epilepsy

Indexed keywords

CYSTATIN B;

APOPTOSIS; ATAXIA; ATROPHY; CSTB GENE; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC CODE; HUMAN; MISSENSE MUTATION; MOLECULAR MECHANICS; MYOCLONUS EPILEPSY; NERVE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STRUCTURAL GENE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 21; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; MYOCLONIC EPILEPSIES, PROGRESSIVE; POINT MUTATION; SEQUENCE HOMOLOGY, AMINO ACID; UNVERRICHT-LUNDBORG SYNDROME;

ATAXIA;

EID: 0041813308     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg338     Document Type: Review

References (68)

1. Abrahamson, M., Barrett, A.J., Salvesen, G. and Grubb, A. (1986) Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem., 261, 11282-11289.
2. Alakurtti, K., Virtaneva, K., Joensuu, T., Palvimo, J.J. and Lehesjoki, A.-E. (2000) Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene, 242, 65-73.
3. Barrett, A.J. (1986) The cystatins, a diverse superfamily of cysteine peptidase inhibitors. Biomed. Biochim. Acta, 45, 1363-1373.
4. Barrett, A.J. et al. (1986) Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem. J., 236, 312.
5. Berkovic, S.F., Andermann, F., Carpenter, S. and Wolfe, L. (1986) Progressive myoclonus epilepsies: specific causes and diagnosis. N. Engl. J. Med., 315, 296-304.
6. Bespalova, I.N., Adkins, S., Pranzatelli, M. and Burmeister, M. (1997a) Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient. Am. J. Med. Genet., 74, 467-471.
7. Bespalova, I.N., Pranzatelli, M. and Burmeister, M. (1997b) G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene. Mutat. Res. Gen., 382, 67-74.
8. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J. and Turk, V. (1988) The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J., 7, 2593-2599.
9. Bonten, E., van der Spoel, A., Fomerod, M., Grosveld, G. and d'Azzo, A. (1996) Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev., 10, 3156-3169.
10. Brömme, D., Rinne, R. and Kirschke, H. (1991) Tight-binding inhibition of cathepsin S by cystatins. Biomed. Biochim. Acta, 50, 631-635.
11. Calkins, C.C., Sameni, M., Koblinski, J., Sloane, B.F. and Moin, K. (1998) Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy. J. Histochem. Cytochem., 46, 745-751.
12. D'Amato, E., Kokaia, Z., Nanobashvili, A., Reeben, M., Lehesjoki, A.-E., Saarma, M. and Linvall, O. (2000) Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons. Eur. J. Neurosci., 12, 1687-1695.
13. DiGiaimo, R., Riccio, M., Santi, S., Galeotti, C., Ambrosetti, D.C. and Melli, M. (2002) New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B. Hum. Mol. Genet., 11, 2941-2950.
14. Eldridge, R., Iivanainen, M., Stem, R., Koerber, T. and Wilder, B.J. (1983) 'Baltic' myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet, 2, 838-842.
15. Feng, Y., Zhang, F., Lokey, L.K., Chastain, J.L., Lakkis, L., Eberhart, D. and Warren, S.T. (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science, 268, 731-734.
16. Ganesh, S. et al. (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum. Mol. Genet., 9, 2251-2261.
17. Gao, H. et al. (2002) Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am. J. Hum. Genet., 70, 324-335.
18. Green, G.D., Kembhavi, A.A., Davies, M.E. and Barret, A.J. (1984) Cystatin-like cysteine proteinase inhibitors from human liver. Biochem. J., 218, 939-946.
19. Haltia, M., Kristensson, K. and Sourander, P. (1969) Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol. Scand., 45, 63-77.
20. International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten Disease, CLN3. Cell, 82, 949-957.
21. Järvinen, M. and Rinne, A. (1982) Human spleen cysteine protease inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants. Biochim. Biophys Acta, 708, 210-217.
22. Jerala, R., Trstenjak, M., Lenarcic, B. and Turk, V. (1988) Cloning a synthetic gene for human stefin B and its expression in E. coli. FEBS Lett., 239, 41-44.
23. Kagitani-Shimono, K., Imai, K., Okamoto, N., Ono, J. and Okada, S. (2002) Unverricht-Lundborg disease with cystatin B gene abnormalities. Pediatr. Neurol., 26, 55-60.
24. Koide, R. et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet., 6, 9-13.
25. Koskiniemi, M., Donner, M., Majuri, H., Haltia, M. and Norio, R. (1974a) Progressive myoclonus epilepsy: a clinical and histopathologic study. Acta Neurol. Scand., 50, 307-332.
26. Koskiniemi, M., Toivakka, E. and Donner, M. (1974b) Progressive myoclonus epilepsy: electroencephalographical findings. Acta Neurol. Scand., 30, 333-359.
27. Lafreniere, R.G. et al. (1997) Unstable insertion in the 5′-flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat. Genet., 15, 298-302.
28. Lalioti, M.D., Scott, H.S., Buresi, C., Rossier, C., Bottani, A., Morris, M.A., Malafosse, A. and Antonarakis, S.E. (1997a) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature, 386, 847-851.
29. Lalioti, M.D. et al. (1997b) Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am. J. Hum. Genet., 60, 342-351.
30. Lalioti, M.D. et al. (1998) A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am. J. Hum. Genet., 62, 842-847.
31. Lalioti, M.D., Scott, H.S. and Antonarakis, S.E. (1999) Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1. Hum. Mol. Genet., 8, 1791-1798.
32. Larson, G.P., Ding, S., Lafrenière, R.G., Rouleau, G.A. and Krontiris, T.G. (1999) Instability of the EPM1 minisatellite. Hum. Mol. Genet., 8, 1985-1988.
33. Lehesjoki, A.-E., Koskiniemi, M., Sistonen, P., Miao, J., Hästbacka, J., Norio, R. and de la Chapelle, A. (1991) Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc. Natl Acad. Sci. USA, 883, 3696-3699.
34. Lehesjoki, A.-E., Koskiniemi, M., Norio, R., Tirrito, S., Sistonen, P., Lander, E. and de la Chapelle, A. (1993) Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. Hum. Mol. Genet., 2, 1229-1234.
35. Lenarcic, B., Krizaj, I., Zunec, P. and Turk, V. (1996) Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. FEBS Lett., 395, 113-118.
36. Lieuallen, K., Pennacchio, L.A., Park, M., Myers, R.M. and Lennon, G.G. (2001) Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum. Mol. Genet., 10, 1867-1871.
37. Machleidt, W., Thiele, U., Assfalg-Machleidt, I., Forger, D. and Auerswald, E.A. (1991) Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins. Biomed. Biochim. Acta, 50, 613-620.
38. Marseille Consensus Group (1990) Classification of progressive myoclonus epilepsies and related disorders. Ann. Neurol., 28, 113-116.
39. Minassian, B.A. et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet., 20, 171-174.
40. Nagafuchi, S. et al. (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat. Genet., 6, 14-18.
41. Norio, R. and Koskiniemi, M. (1979) Progressive myoclonus epilepsy; genetic and nosological aspects with special reference to 107 Finnish patients. Clin. Genet., 15, 382-398.
42. Parsons, M.A., Sinden, R.R. and Izban, M.G. (1998) Transcriptional properties of RNA polymerase II within triplet repeat-containing DNA from the human myotonic dystrophy and fragile X loci. J. Biol. Chem., 273, 26998-27008.
43. Pataskar, S.S., Dash, D. and Brahmachari, S.K. (2001) Progressive myoclonus epilepsy [EPM1] repeat d(CCCCGCCCCGCG)n forms folded hairpin structures at physiological pH. J. Biomol. Struct. Dyn., 19, 293-305.
44. Pennacchio, L.A. et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science, 271, 1731-1734.
45. Pennacchio, L.A., Bouley, D.M., Higgins, K.M., Scott, M.P., Noebels, J.L. and Myers, R.M. (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet., 20, 251-258.
46. Pshezhetsky, A.V. et al. (1997) Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat. Genet., 15, 316-320.
47. Ranta, S. et al. (1999) The neuronal ceroid lipofuscinosis in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet., 23, 233-236.
48. Rawlings, N.D. and Barret, A.J. (1990) Evolution of proteins of the cystatin superfamily. J. Mol. Evol., 30, 60-71.
49. Rawlings, N.D. and Barrett, A.J. (1999) Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis. Biochim. Biophys Acta, 1429, 496-500.
50. Riccio, M., Di Giaimo, R., Pianetti, S, Palmieri, P.P., Melli, M. and Santi, S. (2001) Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res., 262, 84-94.
51. Rinne, A., Järvinen, M., Martikainen, J., Alavaikko, M. and Räsänen, O. (1981) Über das Vorkommen des epidermalen SH-Protease-Inhibitors im lymphatischen Gewebe. Verb. Anat. Ges., 75, 573-574.
52. Rinne, R., Saukko, P., Järvinen, M. and Lehesjoki, A.-E. (2002) Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann. Med., 34, 380-385.
53. Ritonja, A., Machleidt, W. and Barrett, A.J. (1985) Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver. Biochem. Biophys. Res. Commun., 131, 1187-1192.
54. Saha, T. and Ushdin, K. (2001) Tetraplex formation by the progressive myoclonus epilepsy type-1 repeat: implications for instability in the repeat expansion diseases. FEBS Lett. 491, 184-187.
55. Savukoski, M., Klockars, T., Holmberg, V., Santavuori, P., Lander, E.S. and Peltonen, L. (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet., 19, 286-288.
56. Serratosa, J.M. et al. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet., 8, 345-352.
57. Shannon, P., Pennacchio, L.A., Houseweart, M.K., Minassian, B.A. and Myers, R.M. (2002) Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. J. Neuropathol. Exp. Neurol., 61, 1085-1091.
58. Shoffner, J.M., Lott, M.T., Lezza, A.M., Seibel, P., Ballinger, S.W. and Wallace, D.C. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell, 61, 931-937.
59. Sleat, D.E., Donnelly, R.J., Lackland, H., Liu, C.G., Sohar, I., Pullarkat, R.K., and Lobel, P. (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science, 277, 1802-1805.
60. Stone, N.E. et al. (1996) Construction of a 750 kb bacterial clone contig and restriction map in the region of human chromosome 21 containing the progressive myoclonus epilepsy (EPM1) gene. Genome Res., 6, 218-225.
61. Stubbs, M.T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarcic, B. and Turk, V. (1990) The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J., 9, 1939-1947.
62. Turk, V. and Bode, W. (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett., 285, 213-219.
63. Vesa, J., Hellsten, E., Verkruyse, L.A., Camp, L.A., Rapola, J., Santavuori, P., Hoffmann, S.L. and Peltonen, L. (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature, 376, 584-587.
64. Vines, D.J. and Warburton, M.J. (1999) Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett., 443, 131-135.
65. Virtaneva, K. et al. (1996) Progressive myoclonus epilepsy EPM1 locus maps to a 175 kb interval in distal 21q. Am. J. Hum. Genet., 58, 1247-1253.
66. Virtaneva, K. et al. (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat. Genet., 15, 393-396.
67. Wheeler, R.B., Sharp, J.D., Schultz, R.A., Joslin, J.M., Williams, R.E. and Mole, S.E. (2002) The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein Am. J. Hum. Genet., 70, 537-542.
68. Yoneda, M., Tanno, Y., Horai, S., Ozawa, T., Miyatake, T. and Tsuji, S. (1990) A common mitochondrial DNA mutation in the tRNA-lys of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem. Int., 21, 789-796.